Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorder

Neuroendocrinology Letters

Volumn 34, Issue 8, 2013, Pages 780-786

  Gałecki, Piotr ^a   Talarowska, Monika ^a   Bobiñska, Kinga ^a   Kowalczyk, Edward ^a   Gałecka, Elzbieta ^a   Lewiñski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cognitive impairment; Depression; Inflammation; Thiol protein groups

Indexed keywords

ANTIDEPRESSANT AGENT; PROTEIN DERIVATIVE; THIOL GROUP; THIOL PROTEIN GROUP; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUDITORY VERBAL LEARNING TEST; CASE CONTROL STUDY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DECLARATIVE MEMORY; DEPRESSION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; LANGUAGE ABILITY; LANGUAGE TEST; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MIDDLE AGED; NEUROPATHOLOGY; PROTEIN BLOOD LEVEL; PSYCHOLOGIC TEST; PSYCHOPHARMACOTHERAPY; RECURRENT DISEASE; STROOP TEST; VERBAL FLUENCY TEST; WORKING MEMORY; YOUNG ADULT;

ADULT; BLOOD PROTEINS; COGNITION DISORDERS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OXIDATIVE STRESS; RECURRENCE; SEVERITY OF ILLNESS INDEX; STROOP TEST; SULFHYDRYL COMPOUNDS; TRAIL MAKING TEST; YOUNG ADULT;

EID: 84895827425     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ansari MA, Scheff SW (2010). Oxidative stress in the progression of Alzheimer disease in the frontal cortex J Neuropathol Exp Neurol. 69:155-167.
2. Audenaert K, Lohorte P, Brans B, van Laere K, Goethals I, van Heeringen K, Dierckx RA (2001).The classical Stroop interference task as a prefrontal activation probe: a validation study using "Tc'ECD brain SPECT. Nucl Med Commun. 22:135-143. (Pubitemid 32222628)
3. Balcerczyk A, Bartosz G (2003). Thiols are main determinants of total antioxidant capacity of cellular homogenates. Free Radic Res. 37:537-541. (Pubitemid 36410895)
4. Baty JW, Hampton MB, Winterbourn CC (2002). Detection of oxidant-sensitive thiol proteins by fluorescent labeling and two dimensional electrophoresis. Proteomics 2:1261-1266.
5. Benzi G, Moretti A (1995). Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radic Biol Med. 19: 77-101.
6. Butterfield DA, Reed T, Perluigi M, De Marco C, Coccia R, Cini C, Sultana R (2006). Elevated protein-bound levels of the lipid peroxidation product 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci Lett. 397:170-173.
7. Claeyssen R, Andriollo-Sanchez M, Arnaud J, Touvard L, Alonso A, Chancerelle Y, Roussel AM, Agay D (2008). Burn-induced oxidative stress is altered by a low zinc status: Kinetic study in burned rats fed a low zinc diet. Biol Trace Elem Res. 126:80-96.
8. Cruz-Sánchez FF, Girončs X, Ortega A, Alameda F, Lafuente JV (2010). Oxidative stress in Alzheimer's disease hippocampus: A topographical study. J Neurol Sci. 299:163-167.
9. Demyttenaere K, De Fruyt J (2003). Getting what you ask for: on the selectivity of depression rating scales. Psychother Psychosom. 72:61-70. (Pubitemid 36302474)
10. Dickinson DA, Forman HJ (2002). Cellular glutathione and thiols metabolism. Biochem. Pharmacol. 64:1019-1026. (Pubitemid 35238033)
11. Evola M, Hall A, Wall T, Young A, Grammas P (2010). Oxidative stress impairs learning and memory in apoE knockout mice. Pharmacol Biochem Behav. 96:181-186.
12. Fraguas D, Gonzalez-Pinto A, Mico JA, Reig S, Parellada M, Martinez-Cengotitabengoa M, Castro-Fornieles J, Rapado-Castro M, Baeza I, Janssen J, Deseo M, Leza JC, Arango C. (2012).Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study. Schizophr Res. 137:58-65.
13. Gałecki P, Szemraj J, Bieňkiewicz M, Florkowski A, Gaiecka E (2009). Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol Rep. 61:436-447.
14. Gruber O, Zilles D, Kennel J, Gruber E, Falkai P (2011). A systematic experimental neuropsychological investigation of the functional integrity of working memory circuits in major depression. Eur Arch Psychiatry Clin Neurosci. 261:179-184.
15. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
16. Hammar A, Ardal G (2009). Cognitive functioning in major depression-a summary. Front Hum Neurosci. 3:26.
17. Hepp S, Gerich FJ, Müller M (2005). Sulfhydryl oxidation reduces hippocampal susceptibility to hypoxia-induced spreading depression by activating BK channels. J Neurophysiol. 94: 1091-1103. (Pubitemid 41061350)
18. Holmgren A (2000). Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid. Redox Signal 2:811-820.
19. ICD-10 Classification of Mental & Behavioural Disorders (1993). Geneva: World Health Organization.
20. Kupper N, Gidron Y, Winter J, Denollet J (2009). Association between type D personality, depression, and oxidative stress in patients with chronic heart failure. Psychosom Med. 71: 973-980.
21. Łuria A (1976). Neuropsychology. Warsaw: PZWL.
22. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B, Maj M (2009).The inflammatory & neurodegenerativo (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression. Metab Brain Dis. 24:27-53.
23. Maes M, Gałecki P, Chang YS, Berk M (2010). A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 35:676-692.
24. Mandai PK, Tripathi M, Sugunan S (2012). Brain oxidative stress: Detection and mapping of anti-oxidant marker 'Glutathione' in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy. Biochem Biophys Res Commun. 417:43-48.
25. McDowd J, Hoffman L, Rozek E, Lyons KE, Pahwa R, Burns J, Kemper S (2011) . Understanding verbal fluency in healthy aging, Alzheimer's disease, and Parkinson's disease. Neuropsychol. 25: 210-225.
26. Patten S (1997). Performance of the composite international diagnostic interview short form for major depression in community and clinical samples. Chronic Dis Can. 3:18-24.
27. Rice Evans CA, Diplock AT, Symons MCR (1991). In: RH Burdon, PH Knippenberg, editors. Techniques in free radicals research. Amsterdam: Elsevier, pp. 51-100.
28. Rothman SM, Mattson MP (2010). Adverse stress, hippocampal networks, and Alzheimer's disease. Neuromolecular Med. 12: 56-70.
29. Sánchez-Cubillo I, Periáñez J, Adrover-Roig D, Rodriguez-Sánchez JM, Ríos-Lago M, Tirapu J, Barceló F (2009). Construct validity of the trail making test: Role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc. 15:438-451.
30. Talarowska M, Florkowski A, Zboralski K, Berent D, Wierzbiński P, Galecki P (2010). Auditory-verbal declarative and operating memory among patients suffering from depressive disorderspreliminary study. Adv Med Sci. 55:317-327.
31. Talarowska M, Galecki P, Maes M Orzechowska A, Chamielec M, Bartosz G, Kowalczyk E (2012). Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder. Neurosci Lett. 510:127-131.
32. Tanaka M, Ishii A, Yamano E, Ogikubo H, Okazaki M, Kamimura K, Konishi Y, Emoto S, Watanabe Y (2012). Cognitive dysfunction in elderly females with depressive symptoms. Med Sci Monit. 18: 706-711.
33. Tavares JVT, Clark L, Cannon DM, Cannon DM, Erickson K, Drevets WC, Sahakian BJ (2007). Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biol Psychiatry 62:917-924. (Pubitemid 47488228)
34. Uysal N,Tugyan K, Aksu I, Ozbal S, Ozdemir D, Dayi A, Gönenç S, Açikgõz O (2012). Age-related changes in apoptosis in rat hippocampus induced by oxidative stress. J Biotech Histochem. 87: 98-104.
35. Vanguilder HD, Freeman WM (2011). The hippocampal neuroproteome with aging and cognitive decline: Past progress and future directions. Front Aging Neurosci. 3:8.